Search - tctmd.com

Displaying 1 - 20 of 25

Sort: Relevancy | Date

News Daily News

Patients With Obesity Get Biggest Benefit from Evolocumab: FOURIER

Michael O'Riordan

December 12, 2025

News Daily News

Weight-Loss Drug MariTide Gains Momentum in Phase II Trial

Caitlin E. Cox

June 25, 2025

News Daily News

Amylin Analogue Boosts Weight Loss When Added to GLP-1

L.A. McKeown

June 24, 2025

Higher CVD Risk in Children as Young as 10 Who Have Central Adiposity

Michael O'Riordan

May 16, 2025

News Conference News European Congress on Obesity 2025

SELECT: Semaglutide’s Impact on CVD Events Emerges Quickly

Michael O'Riordan

May 14, 2025

News Conference News THT 2025

Tirzepatide Helps in HFpEF Across Spectrum of Obesity Severity

Todd Neale

February 12, 2025

News Daily News

Top General Cardiology and Prevention News of 2024

Caitlin E. Cox

December 30, 2024

SUMMIT: Tirzepatide ‘Huge Win’ for HFpEF Patients With Obesity

News Conference News AHA 2024

SUMMIT: Tirzepatide a ‘Huge Win’ for HFpEF Patients With Obesity

Michael O'Riordan

November 16, 2024

News Daily News

SUMMIT Meets Primary Endpoint for Safety, Efficacy of Tirzepatide: Topline Results

Yael L. Maxwell

August 01, 2024

News Daily News

Semaglutide Has Similar Benefits in Women and Men With HFpEF

Todd Neale

June 26, 2024

News Conference News ACC 2024

STEP-HFpEF DM Trial Hints at Semaglutide HF Effects Beyond Pounds Shed

L.A. McKeown

April 06, 2024

News Daily News

Universal Risk Tool Works Well in Both Primary and Secondary Prevention

Michael O'Riordan

February 01, 2024

News Conference News HFSA 2023

Semaglutide Works Across LVEF Range: STEP-HFpEF Analysis

Todd Neale

October 11, 2023

News Conference News ESC 2023

STEP-HFpEF: Semaglutide Cuts Weight and Symptoms, Boosts Function

Shelley Wood

August 25, 2023

News Daily News

Acute MI Patients Without Standard CVD Risk Factors at Higher Risk of Death

Michael O'Riordan

July 07, 2023

News Daily News

Food Insecurity May Drive Heart Failure, CAD Risks in Black Individuals

L.A. McKeown

February 06, 2023

News Daily News

Vegan Soul Food Study Raises Interesting Questions About ‘Healthy’ Diets

L.A. McKeown

January 18, 2023

News Conference News AHA 2022

Common ‘Heart’ Supplements Can’t Beat Statins: SPORT

Michael O'Riordan

November 06, 2022

News Daily News

Meat Consumption and Gut Microbiome Linked to ASCVD Risk

Yael L. Maxwell

August 03, 2022

News Daily News

AHA: Increased Diabetes, CVD Risk for American Indians, Alaskan Natives

Yael L. Maxwell

May 29, 2020

Advertisement

Patients With Obesity Get Biggest Benefit from Evolocumab: FOURIER

Weight-Loss Drug MariTide Gains Momentum in Phase II Trial

Amylin Analogue Boosts Weight Loss When Added to GLP-1

Higher CVD Risk in Children as Young as 10 Who Have Central Adiposity

SELECT: Semaglutide’s Impact on CVD Events Emerges Quickly

Tirzepatide Helps in HFpEF Across Spectrum of Obesity Severity

Top General Cardiology and Prevention News of 2024

SUMMIT: Tirzepatide a ‘Huge Win’ for HFpEF Patients With Obesity

SUMMIT Meets Primary Endpoint for Safety, Efficacy of Tirzepatide: Topline Results

Semaglutide Has Similar Benefits in Women and Men With HFpEF

STEP-HFpEF DM Trial Hints at Semaglutide HF Effects Beyond Pounds Shed

Universal Risk Tool Works Well in Both Primary and Secondary Prevention

Semaglutide Works Across LVEF Range: STEP-HFpEF Analysis

STEP-HFpEF: Semaglutide Cuts Weight and Symptoms, Boosts Function

Acute MI Patients Without Standard CVD Risk Factors at Higher Risk of Death

Food Insecurity May Drive Heart Failure, CAD Risks in Black Individuals

Vegan Soul Food Study Raises Interesting Questions About ‘Healthy’ Diets

Common ‘Heart’ Supplements Can’t Beat Statins: SPORT

Meat Consumption and Gut Microbiome Linked to ASCVD Risk

AHA: Increased Diabetes, CVD Risk for American Indians, Alaskan Natives

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content